DR. MICHAEL J. BARZA, M.D.
Osteopathic Medicine at Dorchester Ave, Boston, MA
License number
Massachusetts 35917
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
2100 Dorchester Ave, Boston, MA 02124
Phone
(617) 296-4000
(617) 474-3855 (Fax)
(617) 964-4749
(617) 474-3855 (Fax)
(617) 964-4749
Organization information
See more information about MICHAEL J. BARZA at bizstanding.comMichael J Barza MD
800 Washington St, Boston, MA 02111
Categories:
Infectious Disease Physicians & Surgeons, Internal Medicine Physicians & Surgeons
Phone:
(617) 636-7010 (Phone)
Professional information
Michael J Barza, Dorchester Center MA
Specialties:
Infectious Disease Specialist
Address:
2100 Dorchester Ave, Dorchester Center, MA 02124
Education:
McGill University, Faculty of Medicine - Doctor of Medicine
Beth Israel Deaconess Medical Center - Fellowship - Infectious Disease (Internal Medicine)
McGill University Health Centre - Residency - Family Medicine
McGill University Health Centre-The Royal Victoria Hospital - Residency - Family Medicine
Beth Israel Deaconess Medical Center - Fellowship - Infectious Disease (Internal Medicine)
McGill University Health Centre - Residency - Family Medicine
McGill University Health Centre-The Royal Victoria Hospital - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)
Dr. Michael J Barza, Boston MA - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
Tufts Medical Center Geographic Medicine and Infectious Diseases
800 Washington St STE 79, Boston 02111
(617) 636-7010 (Phone), (617) 636-7100 (Fax)
CARNEY HOSPITAL
2100 Dorchester Ave, Dorchester 02124
(617) 296-4000 (Phone), (617) 474-3847 (Fax)
Dorchester Center Office
2100 Dorchester Ave, Dorchester 02124
(617) 296-4000 (Phone), (617) 479-0857 (Fax)
800 Washington St STE 79, Boston 02111
(617) 636-7010 (Phone), (617) 636-7100 (Fax)
CARNEY HOSPITAL
2100 Dorchester Ave, Dorchester 02124
(617) 296-4000 (Phone), (617) 474-3847 (Fax)
Dorchester Center Office
2100 Dorchester Ave, Dorchester 02124
(617) 296-4000 (Phone), (617) 479-0857 (Fax)
Certifications:
Infectious Disease, 1974, Internal Medicine, 1971
Awards:
Healthgrades Honor Roll
Languages:
English, French
Hospitals:
Tufts Medical Center Geographic Medicine and Infectious Diseases
800 Washington St STE 79, Boston 02111
CARNEY HOSPITAL
2100 Dorchester Ave, Dorchester 02124
Dorchester Center Office
2100 Dorchester Ave, Dorchester 02124
Carney Hospital
2100 Dorchester Ave, Dorchester 02124
800 Washington St STE 79, Boston 02111
CARNEY HOSPITAL
2100 Dorchester Ave, Dorchester 02124
Dorchester Center Office
2100 Dorchester Ave, Dorchester 02124
Carney Hospital
2100 Dorchester Ave, Dorchester 02124
Education:
Medical School
MCGILL UNIVERSITY / FACULTY OF MEDICINE
Royal Victoria Hospital
Queen Elizabeth Hosp
Beth Israel Deaconess Medical Center
MCGILL UNIVERSITY / FACULTY OF MEDICINE
Royal Victoria Hospital
Queen Elizabeth Hosp
Beth Israel Deaconess Medical Center
Determination Of Antimicrobial Susceptibilities On Infected Urines Without Isolation
US Patent:
4132599, Jan 2, 1979
Filed:
Apr 23, 1976
Appl. No.:
5/680015
Inventors:
James C. Administrator of the National Aeronautics and Space Fletcher
Grace L. Picciolo - Tantallon MD
Emmett W. Chappelle - Baltimore MD
Jody W. Deming - Annapolis MD
Christian G. Shrock - Eding MN
Hillar Vellend - Toronto, CA
Michael J. Barza - Boston MA
Louis Weinstein - Newtonville MA
Grace L. Picciolo - Tantallon MD
Emmett W. Chappelle - Baltimore MD
Jody W. Deming - Annapolis MD
Christian G. Shrock - Eding MN
Hillar Vellend - Toronto, CA
Michael J. Barza - Boston MA
Louis Weinstein - Newtonville MA
International Classification:
C12K 100
US Classification:
1951035K
Abstract:
Method for the quick determination of the susceptibilities of various unidentified bacteria contained in an aqueous physiological fluid sample, particularly urine, to one or more antibiotics. A bacterial adenosine triphosphate (ATP) assay is carried out after the elimination of non-bacterial ATP to determine whether an infection exists. If an infection does exist, a portion of the sample is further processed, including subjecting parts of the portion to one or more antibiotics. Growth of the bacteria in the parts are determined, again by an ATP assay, to determine whether the unidentified bacteria in the sample are susceptible to the antibiotic or antibiotics under test.
Application Of Luciferase Assay For Atp To Antimicrobial Drug Susceptibility
US Patent:
4014745, Mar 29, 1977
Filed:
Apr 30, 1975
Appl. No.:
5/572991
Inventors:
James C. Administrator of the National Aeronautics and Space Fletcher
Emmett W. Chappelle - Baltimore MD
Grace L. Picciolo - Tantallon MD
Hillar Vellend - Newton Upper Falls MA
Stephanie A. Tuttle - Watertown MA
Michael J. Barza - Boston MA
Louis Weinstein - Newtonville MA
Emmett W. Chappelle - Baltimore MD
Grace L. Picciolo - Tantallon MD
Hillar Vellend - Newton Upper Falls MA
Stephanie A. Tuttle - Watertown MA
Michael J. Barza - Boston MA
Louis Weinstein - Newtonville MA
International Classification:
C12K 104
US Classification:
1951035K
Abstract:
The susceptibility of bacteria, particularly those derived from body fluids, to antimicrobial agents is determined in terms of an ATP index measured by culturing a bacterium in a growth medium, assaying the amount of ATP in a sample of the cultured bacterium by measuring the amount of luminescent light emitted when the bacterial ATP is reacted with a luciferase-luciferin mixture, subjecting the sample of the cultured bacterium to an antibiotic agent and assaying the amount of bacterial adenosine triphosphate after treatment with the antibiotic by measuring the luminescent light resulting from the reaction, whereby the ATP index is determined from the values obtained from the assay procedures.